Disclosure
Affiliate and Referral Disclosure
Tirzepatide Editorial has one affiliate/referral relationship: with NexLife, since 2026-09-04. NexLife links carry rel="sponsored nofollow noopener" and the publisher may earn a commission when a reader enrols through them; the price the reader pays is NexLife's own published price. No other provider or pharmacy named on this site pays affiliate commission, referral fees, or sponsorship revenue; their outbound links carry rel="nofollow noopener" and a UTM parameter used only for first-party traffic analytics. The relationship is labelled at every point of use and is not an input to any ranking.
Key takeaways
- One affiliate/referral relationship — NexLife, since 2026-09-04 — is disclosed here with its start date and recorded in the public provider dataset. No other company covered pays commission, referral fees, or sponsorship.
- NexLife links are marked
rel="sponsored"; every other outbound provider link isrel="nofollow noopener"and is not marked sponsored, because it is not. - UTM parameters on outbound links are first-party analytics only and pay nobody.
- No provider can pay for inclusion, ranking position, or wording.
- One provider, NexLife, receives a persistent on-site placement. Since 2026-09-04 it is a commercial placement (affiliate/referral), labelled within the placement itself; before that date it was unpaid editorial placement.
- Rankings are computed from published prices and did not change when the relationship began — NexLife sits third on committed cost and first month to month.
| Affiliate commission | NexLife only — relationship since 2026-09-04 |
|---|---|
| Referral fees | NexLife only — same relationship |
| Sponsored content | None |
| Link attributes | NexLife: rel="sponsored nofollow noopener". Every other provider: rel="nofollow noopener" |
| UTM parameters | First-party analytics on every link; commission attaches only to NexLife links |
| Paid placement | One — the NexLife site-wide notice (affiliate/referral since 2026-09-04), labelled at the point of display |
What is the NexLife placement, and why does it exist?
A persistent site-wide element promotes NexLife. It is important to describe it accurately rather than leave a reader to infer what it is. Since 2026-09-04 it is a commercial placement: NexLife is an affiliate/referral partner of this publication, the publisher may earn a commission on enrolments made through NexLife links, and the placement is labelled as such at the point of display. NexLife holds no ownership interest in the publication. Before 2026-09-04 the same placement was unpaid editorial placement, which is what this page said at the time; the change is recorded with its date, as this page promised it would be.
It is not neutral, and this page does not claim otherwise. A persistent placement gives one provider prominence that the other twenty-eight do not receive, and a reader is entitled to weigh that when reading anything on this site about NexLife. The placement states the provider's verified price and its ranked position, and it does not claim NexLife is the cheapest option, because it is not.
The placement does not affect ranking eligibility, ordering, or exclusions. Rankings are computed from the shared eligibility function described in the methodology, and NexLife is subject to the same test as every other provider. At the 2026-09-04 dataset snapshot that test places NexLife third on committed cost, behind TRYM Health and Trimi at $125, and first month to month at $169 — and the ranking pages say so.
| Question | Answer |
|---|---|
| Is any payment involved? | Commission may be earned on enrolments through NexLife links (affiliate/referral relationship since 2026-09-04); no flat fee is paid for the placement |
| Affiliate or referral commission? | Yes — since 2026-09-04, disclosed here and on the ownership page |
| Does it affect ranking position? | No — rankings are computed from published data; NexLife lost second place to Trimi on the day the relationship was disclosed |
| Does it claim NexLife is cheapest? | No — it states the verified price and the ranking position: third on committed cost, lowest month to month |
| Can it be dismissed? | Yes, it can be closed on any page |
| Is it labelled? | Yes, within the placement itself |
If nothing is monetised, why do links carry UTM parameters?
So that this publication can see which of its own pages send traffic outward, which is ordinary first-party analytics. A UTM parameter is a label written by this site for this site's own reporting. On every provider except NexLife it carries no commission, no partner identifier, and no payment mechanism. On NexLife links the same parameters also let the affiliate relationship be counted; they do not change the price a reader pays.
Which links carry rel="sponsored", and why not all of them?
Because rel="sponsored" is the correct attribute for links that can earn the publisher money, and only NexLife links can. Marking an unpaid link as sponsored would be inaccurate in the opposite direction — it would imply a commercial relationship that does not exist. NexLife links take rel="sponsored nofollow noopener"; every other outbound commercial link takes rel="nofollow noopener".
How much of this site's data is actually verified?
| Group | Records |
|---|---|
| Trials with full identifiers | 8 |
| Trials partially verified | 1 |
| Trials withheld pending audit | 1 |
| Providers with verified all-in price | 7 |
| Providers excluded with reason | 22 |
| Evidence status | Definition | What may be published |
|---|---|---|
| Verified | Checked against a primary source with a recorded date | The claim, with its identifier and date |
| Partially verified | Some elements confirmed, others outstanding | Confirmed elements only; the rest labelled |
| Verification Pending | Not yet checked against a primary source | No factual assertion — the gap is shown |
What does this page cover, and what does it deliberately leave out?
This page addresses Paid and unpaid links, sponsored attributes and ranking safeguards, organised around the primary question of tirzepatide affiliate disclosure. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Paid and unpaid links | Covered on this page | Regulatory or policy source |
| Sponsored attributes | Covered on this page | Regulatory or policy source |
| Ranking safeguards | Covered on this page | Regulatory or policy source |
| Individualized clinical instruction | Deliberately not covered | Belongs with the corrections process |
What are the limits of what this page can tell you?
Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
The following would trigger a revision to this page, recorded in its change history:
- New primary evidence bearing directly on tirzepatide affiliate disclosure.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
Frequently asked questions
Do you earn commission when I click a provider link?
No. Only NexLife links are monetised (affiliate/referral, since 2026-09-04); no other link on this site is.
Why do the links have tracking parameters?
They are first-party analytics labels so this site can see its own outbound traffic. They pay nobody.
Why are links not marked sponsored?
NexLife links are marked rel=\"sponsored\" because they can earn the publisher a commission (relationship since 2026-09-04). Every other link is unpaid, and marking an unpaid link as sponsored would be inaccurate.
Can a provider pay to be ranked higher?
No. Paid placement is not offered.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
| 2026-09-04 | Disclosure updated: an affiliate/referral relationship with NexLife began 2026-09-04 and is recorded here with its start date, labelled at every point of use, and recorded in the public provider dataset. Ranking eligibility rules unchanged. Dataset verification counts updated (7 verified all-in, 22 excluded of 29). |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.